U.S. Health and Human Services Secretary Robert F. Kennedy Jr. launched initiatives to reduce prescriptions of SSRIs, the most common antidepressants, by introducing new trainings and guidelines for clinicians. This matters to tech professionals as it signals a shift towards integrating digital health solutions like teletherapy platforms into treatment plans. Johnson & Johnson's combined IBD therapy showed promise but fell short of primary endpoints in Phase 2b trials, indicating continued research focus on specific patient subgroups.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



